Showing 1-10 of about 15 articles.
Research and Markets
Dublin, Feb. 15, 2021 (GLOBE NEWSWIRE) -- The "Medical Image Analysis Software Market Research Report by Software, by Image Type, by Modality , by Application, by End User - United States Forecast...
Fior Markets
Newark, NJ, Feb. 09, 2021 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global advanced visualization market is expected to grow from USD 3.07 billion in 2020 to USD 6.77...
Research and Markets
Dublin, Jan. 20, 2021 (GLOBE NEWSWIRE) -- The "Medical Imaging Information Systems - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. The...
Research and Markets
Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) -- The "Positron Emission Tomography [PET] Scanners Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been...
Research and Markets
Dublin, Dec. 22, 2020 (GLOBE NEWSWIRE) -- The "Nuclear Imaging Devices and Equipment Global Market Report 2020-30: COVID-19 Impact and Recovery" report has been added to ResearchAndMarkets.com's...
Reports and Data
New York, July 24, 2019 (GLOBE NEWSWIRE) -- This report on the Positron Emission Tomography market is a thorough analysis of the size, share, demand, growth, gross profits, earnings, and revenue of...
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the...
RadioMedix Inc.
Houston, TX and St. Louis, MO, Jan. 09, 2019 (GLOBE NEWSWIRE) -- RadioMedix Inc. and its commercial partner Curium announced today that their investigational diagnostic radiopharmaceutical,...
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
Telix Pharmaceuticals Limited; Nihon Medi-Physics Co., Ltd.
MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
Showing 1-10 of about 15 articles.
